跳转至内容
Merck

L1167

Sigma-Aldrich

拉坦前列素

≥98% (HPLC)

别名:

异丙基 (5Z,9α,11α,15R)-9,11,15-三羟基-17-苯基-18,19,20-三硝基苯-5-烯-1-酸酯, 异丙基 ( Z )-7-[(1 R ,2 R ,3 R ,5 S )-3,5-二羟基-2-[(3 R )-3-羟基-5-苯戊基] 环戊基] 庚烯-5-酸酯, 适利达

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C26H40O5
分子量:
432.59
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

oil

顏色

colorless to yellow

溶解度

DMSO: freely soluble
methanol: soluble

起源

Johnson & Johnson

運輸包裝

wet ice

儲存溫度

−20°C

SMILES 字串

CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2

InChI

1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1

InChI 密鑰

GGXICVAJURFBLW-CEYXHVGTSA-N

基因資訊

human ... PTGFR(5737)

正在寻找类似产品? 访问 产品对比指南

應用

拉坦前列素已被用于:
  • 制备包含姜黄素纳米颗粒(CUR-NP)的热敏水凝胶,以确定其在氧化应激下对人小梁网(TM)细胞的治疗作用。
  • 作为酯类前药用于研究其对小鼠鼠眼表面的作用
  • 制备热敏水凝胶用于研究其对控制高眼压症的作用。

生化/生理作用

拉坦前列素是一种强效、选择性前列腺素F2 α类似物受体激动剂。它在角膜中被酯酶水解为拉坦前列素酸的生物活性形式。拉坦前列素在降低眼内压(IOP)方面起一定作用,因此它具有治疗青光眼的疗效。

特點和優勢

《受体分类和信号转导》手册的 前列腺素类受体 页面有该化合物的介绍。想要浏览手册的其他页面, 请单击此处
该化合物由 Johnson & Johnson 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表,请点击此处

象形圖

Health hazard

訊號詞

Warning

危險聲明

危險分類

Repr. 2

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Faceshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

F Honrubia et al.
The British journal of ophthalmology, 93(3), 316-321 (2008-11-21)
To conduct a meta-analysis of randomised clinical trials (RCTs) in order to evaluate the development of conjunctival hyperaemia after the use of latanoprost versus travoprost and bimatoprost, in patients with ocular hypertension or glaucoma. In order to identify the potentially
Matthew B Schlenker et al.
Journal of ophthalmology, 2015, 547960-547960 (2015-04-30)
Objective. Compare glaucoma medication costs between the United States (USA) and Canada. Methods. We modelled glaucoma brand name and generic medication annual costs in the USA and Canada based on October 2013 Costco prices and previously reported bottle overfill rates
Sanae Abe et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 29(1), 55-60 (2012-10-11)
To clarify the mechanism of prostaglandin (PG) analogue-dependent relaxation in ciliary arteries from wild-type (WT) and prostanoid receptor-deficient mice. The intracellular-free calcium concentration ([Ca(2+)](i)) in isolated WT mouse ciliary arteries was measured by fluorescence photometry. Reduction of [Ca(2+)](i) leading to
A T Fung et al.
The British journal of ophthalmology, 91(1), 62-68 (2006-09-08)
To compare the efficacy and tolerability of latanoprost versus brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma. Systematic review of randomised controlled trials comparing latanoprost and brimondine, identified by searches including Medline, Embase and Cochrane Controlled
Anastasios G P Konstas et al.
The British journal of ophthalmology, 97(12), 1510-1515 (2013-05-18)
To compare 24 h intraocular pressure (IOP) control obtained with preservative free (PF) tafluprost 0.0015% versus branded preservative containing latanoprost 0.005% administered as first choice monotherapy in patients with primary open angle glaucoma (POAG) or ocular hypertension (OHT). This prospective

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门